76ers Add Anfernee Simons on Two-Year Deal

The Philadelphia 76ers continued reshaping their roster Thursday, agreeing to a two-year, $12.3 million contract with free agent guard Anfernee Simons, according to ESPN.

The reported agreement came one day after Philadelphia reportedly acquired former NBA Finals MVP Jalen Brown from the Boston Celtics. Simons, 27, played alongside Brown in Boston last season and is expected to have a player option in the second year of his new deal, according to the report.

As part of the reported Brown trade, the 76ers will send veteran forward Paul George to the Celtics, along with first-round picks in 2028 and 2031 and second-round selections in 2028 and 2030.

Simons joined Boston last July in the deal that sent Jrue Holiday to the Portland Trail Blazers. He appeared in 49 games for the Celtics, averaging 14.2 points while shooting 39.5% from 3-point range.

He was traded again in February, moving to the Chicago Bulls in exchange for forward Nikola Vucevic. However, a left wrist injury limited Simons to six games with Chicago before ending his season.

Across 55 games, including five starts, Simons averaged 14.3 points, 2.5 rebounds and 2.4 assists.

A first-round pick by Portland in the 2018 NBA Draft, selected No. 24 overall, Simons is expected to provide scoring depth for a Philadelphia bench that lacked consistent offensive production last season. He has averaged at least 17 points per game in four different seasons and owns a career 38.5% mark from 3-point range.

Over eight NBA seasons, Simons has averaged 14.9 points, 3.2 assists and 2.5 rebounds in 444 games, including 218 starts.

Lucas Durden

Guest Writer

Recent Posts

Chicago Fire Sign Anzor Mekvabishvili

Chicago Fire FC announced Sept. 1 that it has acquired Georgian midfielder Anzor Mekvabishvili from Romanian Liga 1 club Universitatea…

1 hour ago

Chicago Mayor, Council Clash Over Budget Oversight

Chicago Mayor Brandon Johnson and members of the City Council are heading into a contentious budget season as disagreements intensify…

1 day ago

FDA Approves Revolution Medicines Pancreatic Cancer Drug

The U.S. Food and Drug Administration has approved Revolution Medicines’ targeted cancer drug Rasonque for certain adults with metastatic pancreatic…

2 days ago

Chicago History Museum Workers Ratify First Contract

Workers at the Chicago History Museum ratified their first union contract on August 25, 2026, with 96% of union members…

6 days ago

White Sox, Rangers Battle for Playoff Position

The Chicago White Sox and Texas Rangers head into Wednesday’s series finale at Rate Field with both clubs fighting for…

1 week ago

Chicago Business Expo Returns to Malcolm X College

Chicago will hold its final Business Resource Expo of 2026 on Saturday, Aug. 29, at Malcolm X College, bringing entrepreneurs…

1 week ago

This website uses cookies.